Table 6 Diagnosis, and treatment of Kawasaki disease shock syndrome, and Septic shock group
From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study
KDSS(n=13) | SS (n=29) | P value | |
|---|---|---|---|
Diagnosis | |||
Initial diagnosis of KD | 23.1% (3/13) | 0%(0/29) | 0.025 |
Complete KD | 46.2% (6/13) | 0%(0/29) | 0.000 |
Incomplete KD | 38.5% (5/13) | 3.4%(1/29) | 0.007 |
Treatment | |||
1st IVIG | 84.6% (11/13) | 51.7% (15/29) | 0.084 |
2nd IVIG | 76.9% (10/13) | 17.2% (5/29) | 0.000 |
Oral prednisolone | 7.7% (1/13) | 0.0%(0/29) | 0.310 |
Methylprednisolone pulse therapy | 38.5% (5/13) | 0.0%(0/29) | 0.002 |
Infliximab | 15.4% (2/13) | 0.0%(0/29) | 0.091 |
Antibiotics | 92.3% (12/13) | 100.0%(29/29) | 0.310 |